Skip to main content

Advertisement

Log in

Adiponectin, HOMA-Adiponectin, HOMA-IR in Children and Adolescents: Ouro Preto Study

  • Original Article
  • Published:
Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Objectives

To examine the association and predictive capacity of adiponectin levels, HOMA-AD and HOMA-IR indexes with metabolic risk markers in children and adolescents.

Methods

A cross-sectional study was conducted with 691 children and adolescents (7–14 y), of both sexes. Demographic (sex, age), anthropometric (weight, height, body mass index, waist circumference, body fat), biochemical [total cholesterol, high density lipoprotein (HDL), low density lipoprotein (LDL), triglycerides, fasting glycemia, insulin and adiponectin] and clinical parameters (arterial blood pressure) were analyzed.

Results

In multiple linear regression models, metabolic risk were analyzed in relation to adiponectin levels, HOMA-AD and HOMA-IR. ROC curve analysis was used to define the cut-off for metabolic syndrome for each method studied. Adiponectin level was inversely correlated with weight (r = −0.12; p = 0.01), waist circumference (WC) (r = −0.12; p = 0.01), and triglycerides (r = −0.11; p = 0.02); it was directly correlated with HDL (r = 0.10; p = 0.03) only in the adolescents. In the final linear regression model, after adjustment, only triglycerides (p = 0.03) and HDL (p = 0.04) remained significant. However, HOMA-AD and HOMA-IR were associated with metabolic risk and were the most suitable methods for metabolic syndrome screening in both age groups. For children, independent variables explained 16.0% and 14.5% of HOMA-AD and HOMA-IR, respectively. For adolescents, R2 was higher in HOMA-AD and HOMA-IR models (R2adjusted = 31.9% and R2adjusted = 29.6%, respectively).

Conclusions

HOMA-AD and HOMA-IR are better explained by metabolic markers than adiponectin levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Magge SN, Goodman E, Armstrong SC, Committee on Nutrition Section on Endocrinology, Section on Obesity. The metabolic syndrome in children and adolescents: Shifting the focus to cardiometabolic risk factor clustering. Pediatrics. 2017;140:e20171603.

    Article  Google Scholar 

  2. Magge SN, Stettler N, Koren D, et al. Adiponectin is associated with favorable lipoprotein profile, independent of BMI and insulin resistance, in adolescents. J Clin Endocrinol Metab. 2011;96:1549–54.

    Article  CAS  Google Scholar 

  3. De Las HJ, Lee S, Bacha F, Tfayli H, Arslanian S. Cross-sectional association between blood pressure, in vivo insulin sensitivity and adiponectin in overweight adolescents. Horm Res Paediatr. 2011;76:379–85.

    Article  Google Scholar 

  4. Nakamura K, Fuster JJ, Walsh K. Adipokines: a link between obesity and cardiovascular disease. J Cardiol. 2014;63:250–9.

    Article  Google Scholar 

  5. Lago F, Dieguez C, Gómez-Reino J, Gualillo O. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev. 2007;18:313–25.

    Article  CAS  Google Scholar 

  6. Brochu-Gaudreau K, Rehfeldt C, Blouin R, Bordignon V, Murphy BD, Palin MF. Adiponectin action from head to toe. Endocrine. 2010;37:11–32.

    Article  CAS  Google Scholar 

  7. Saarikoski LA, Juonala M, Huupponen R, et al; The Cardiovascular Risk in Young Finns Study. Low serum adiponectin levels in childhood and adolescence predict increased intima-media thickness in adulthood. Ann Med. 2017;49:42–50.

  8. Matsuhisa M, Yamasaki Y, Emoto M, Shimabukuro M, Funahashi T, Matsuzawa Y. A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects. Diabetes Res Clin Pract. 2007;77:151–4.

    Article  CAS  Google Scholar 

  9. Hung AM, Sundell MB, Egbert P, et al. A comparison of novel and commonly-used indices of insulin sensitivity in African American chronic hemodialysis patients. Clin J Am Soc Nephrol. 2011;6:767–74.

    Article  CAS  Google Scholar 

  10. Makni E, Moalla W, Lac G, et al. The homeostasis model assessment-adiponectin (HOMA-AD) is the most sensitive predictor of insulin resistance in obese children. Annalesd’ Endocrinologie. 2012;73:26–33.

    Article  CAS  Google Scholar 

  11. Abrantes MM, Lamounier JA, Colosimo EA. Prevalência de sobrepeso e obesidade nas regiões Nordeste e Sudeste do Brasil. Rev Assoc Med Bras. 2003;49:162–6.

    Article  Google Scholar 

  12. Sociedade Brasileira de Cardiologia. VI Diretrizes Brasileiras de Hipertensão Arterial. Rev Bras Hipertens. 2010;17:7–10.

    Google Scholar 

  13. Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85:660–7.

    Article  Google Scholar 

  14. Zimmet P, Alberti KG, Kaufman F, et al; IDF Consensus Group. The metabolic syndrome in children and adolescents- An IDF consensus report. Pediatr Diabetes. 2007;8:299–306.

  15. Ahrens W, Moreno L, Mårild S, et al; IDEFICS Consortium. Metabolic syndrome in young children: definitions and results of the IDEFICS study. Int J Obes. 2014;38:S4–14.

  16. Riestra P, Garcia-Anguita A, Ortega L, Garcés C. Relationship of adiponectin with sex hormone levels in adolescents. Horm Res Paediatr. 2013;79:83–7.

    Article  CAS  Google Scholar 

  17. Snehalatha C, Yamuna A, Ramachandran A. Plasma adiponectin does not correlate with insulin resistance and cardiometabolic variables in nondiabetic Asian Indian teenagers. Diabetes Care. 2008;31:2374–9.

    Article  CAS  Google Scholar 

  18. Lausten-Thomsen U, Christiansen M, Fonvig CE, et al. Reference values for serum total adiponectin in healthy non-obese children and adolescents. Clin Chim Acta. 2015;450:11–4.

    Article  CAS  Google Scholar 

  19. Rank M, Siegrist M, Wilks DC, et al. The cardio-metabolic risk of moderate and severe obesity in children and adolescents. J Pediatr. 2013;163:137–42.

    Article  Google Scholar 

  20. Abreu VG, Martins CJM, de Oliveira PAC, Francischetti EA. High-molecular weight adiponectin/HOMA-IR ratio as a biomarker of metabolic syndrome in urban multiethnic Brazilian subjects. PLoS One. 2017;12:e0180947.

    Article  Google Scholar 

  21. Almeda-Valdes P, Cuevas-Ramos D, Mehta R, et al. Total and high molecular weight adiponectin have similar utility for the identification of insulin resistance. Cardiovasc Diabetol. 2010;9:26.

    Article  Google Scholar 

  22. Klünder-Klünder M, Flores-Huerta S, García-Macedo R, Peralta-Romero J, Cruz M. Adiponectin in eutrophic and obese children as a biomarker to predict metabolic syndrome and each of its components. BMC Public Health. 2013;13. https://doi.org/10.1186/1471-2458-13-88.

  23. Galler A, Gelbrich G, Kratzsch J, Noack N, Kapellen T, Kiess W. Elevated serum levels of adiponectin in children, adolescents and young adults with type 1 diabetes and the impact of age, gender, body mass index and metabolic control: a longitudinal study. Eur J Endocrinol. 2007;157:481–9.

    Article  CAS  Google Scholar 

  24. Brambilla P, Antolini L, Street ME, et al. Adiponectin and hypertension in normal-weight and obese children. Am J Hypertens. 2013;26:257–64.

    Article  CAS  Google Scholar 

  25. Rubin DA, McMurray RG, Hackney AC, Harrell JS. Relationship between cardiovascular risk factors and adipokines in adolescents. Horm Res Paediatr. 2011;76:123–9.

    Article  CAS  Google Scholar 

  26. Dyck DJ, Heigenhauser GJ, Bruce CR. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol. 2006;186:5–16.

  27. Adelantado-Renau M, Jiménez-Pavón D, Beltran-Valls MR, Ponce-González JG, Chiva-Bartoll Ó, Moliner-Urdiales D. Fitness and academic performance in adolescents. The mediating role of Leptin: DADOS study. Eur J Pediatr. 2018;177:1555–63.

  28. Queiroz AM, Santos EM, Castro IM, et al. Genetic composition of a Brazilian population: the footprint of the gold cycle. Genet Mol Res. 2013;12:5124–33.

  29. Dastani Z, Hivert MF, Timpson N, et al. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet. 2012;8:e1002607.

  30. Schutte AE, Huisman HW, Schutte R, et al. Differences and similarities regarding adiponectin investigated in African and Caucasian women. Eur J Endocrinol. 2007;157:181–8.

  31. Comuzzie AG, Funahashi T, Sonnenberg G, et al. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab. 2001;86:4321–5.

Download references

Author information

Authors and Affiliations

Authors

Contributions

APCC performed the statistical analysis and wrote the paper with contributions from all authors. BG coordinated adiponectin determinations and reviewed the paper. ACJV and AC were responsible for making adiponectin determinations. RNF and SNF coordinated the insulin determinations and reviewed the paper. GLLMC conceived and designed the cross-sectional study, coordinated the project and reviewed the paper. All the authors critically contributed to the discussion and data interpretation, reviewed and approved the final manuscript. GLLMC is the guarantor for this paper.

Corresponding author

Correspondence to A. P. C. Cândido.

Ethics declarations

Ethical Approval

This project was approved by the Institutional Review Board of the Federal University of Ouro Preto (Protocol Number 2004/46). Informed consent was obtained from all individual participants included in the study.

Conflict of Interest

None.

Source of Funding

The authors thank Conselho Nacional de Desenvolvimento Cientifico e Tecnológico, CNPq (Grant n.o 474.965/04) and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, CAPES for financial support. GLLMC is recipient of a CNPq individual research grant for productivity.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cândido, A.P.C., Geloneze, B., Calixto, A. et al. Adiponectin, HOMA-Adiponectin, HOMA-IR in Children and Adolescents: Ouro Preto Study. Indian J Pediatr 88, 336–344 (2021). https://doi.org/10.1007/s12098-020-03444-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-020-03444-3

Keywords

Navigation